Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4 Ohio Dr
Ste 200
Lake Success, NY 11042Phone+1 516-775-4545Fax+1 516-775-4646
Summary
- Physician specializing in Nephrology, Hypertension and Internal Medicine;
Clinician + Researcher + Educator
Education & Training
- University of Chicago Booth School of BusinessMBA, Business Administration , 2013 - 2015
- Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2005 - 2009
- The Ohio State University School of Public HealthMPH, 2002 - 2005
- Christ Hospital2000 - 2001
- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1997 - 2000
- Baroda Medical CollegeClass of 1996
Certifications & Licensure
- NY State Medical License 2005 - 2026
- CT State Medical License 2017 - 2018
- MA State Medical License 2005 - 2016
- OH State Medical License 2001 - 2006
- IL State Medical License 1997 - 2002
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Leadership Award American College of Physicians, 2015
- Leadership award American College of Physician, 2012
- Outstanding Contribution to Medicine Department University of Ilinois - Christ Hospital, 2001
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsAnemia in Chronic Kidney Disease: New AdvancesTejas V. Patel, Ajay K. Singh
Heart Failure Clinics. 2010-07-01 - Darbepoetin decreased transfusions and fatigue, but increased adverse effects in patients with chronic kidney disease, diabetes, and anemiaTejas V. Patel
Annals of Internal Medicine. 2010-03-16 - 33 citationsCardiovascular complications in diabetic kidney disease.Tejas V. Patel, David M. Charytan
Seminars in Dialysis. 2010-03-01
Journal Articles
- Serum amyloid P inhibits fibrosis through FcγR-dependentc monocyte-macrophage regulation in vivo.Castaño AP, Lin SL, Surowy T, Nowlin BT, Turlapati SA, Patel T, Singh AK, Li S, Lupher Jr. ML, Duffield JS, Science Translational Medicine 1: 1-11, 11/4/2009
- Route of Epoetin Administration Influences Hemoglobin Variability in Hemodialysis Patients.Patel TV, Hirter A, Kaufman JS, Keithi-Reddy SR, Reda D, Singh AK, Am J Nephrology 29(6):532-7
- Markers of Endothelial Activation in Anemic Non-Dialysis Chronic Kidney Disease Patients.Patel TV, Mittal BV, Keithi Reddy SR, Duffield J, Singh AK, Nephron Clinical Practice
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Kidney Disease Quality Outcome Initiative (K/DOQI GUIDELINES) for Bone and Mineral Metabolism: Emerging Questions.Patel TV, Singh AK, Seminars in Nephrology 29(2):105-12
- Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma (mRCC) with severe renal impairment or on haemodialysis.Josephs DH, Hutson TE, Pickering LM, Larkin JM, Choueiri TK, Patel TV, Mcdermott DF, Powles T, Harper PG, Chowdhury S, American Society of Clinical Oncology
- Soluble P-selectin, Circulating Microparticles and CD40 Ligand levels in Chronic Kidney Disease Patients on Erythropoiesis Stimulating Agents.Keithi Reddy SR, Hoppensteadt DA, Patel TV, Mittal BV, Bansal VK,Fareed J, Singh AK, American Society of Nephrology Annual Meeting
- Join now to see all
Other
- Intensive Glucose Management in Type 1 Diabetes Mellitus Preserves Glomerular Filtration Rate.Patel TV
http://www.thekidneydoctor.org - Epidermal Growth Factor Receptor – A New Treatment Target for Rapidly Progressive Glomerulonephritis?Patel TV
http://www.thekidneydoctor.org
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: